This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Athar, M. Articles by Xie, J. Search for Related Content PubMed PubMed Citation Articles by Athar, M. Articles by Xie, J.

Inhibition of Smoothened Signaling Prevents Ultraviolet B-Induced Basal Cell Carcinomas through Regulation of Fas Expression and Apoptosis

¹ Department of Dermatology, College of Physicians and Surgeons, Columbia University, New York, New York; ² Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland; ³ Department of Dermatology and Comprehensive Cancer Center, University of California San Francisco, San Francisco, California; ⁴ Department of Dermatology, University of Texas Health Science Center, Houston, Texas; ⁵ Sealy Centers for Cancer Cell Biology and Environmental Health, Department of Pharmacology and Toxicology, University of Texas Medical Branch at Galveston, Galveston, Texas; and ⁶ Xijing Hospital, Xi’an 710032, China

Abnormal activation of the hedgehog-signaling pathway is the pivotal abnormality driving the growth of basal cell carcinomas (BCCs), the most common type of human cancer. Antagonists of this pathway such as cyclopamine may therefore be useful for treatment of basal cell carcinomas and other hedgehog-driven tumors. We report here that chronic oral administration of cyclopamine dramatically reduces (66%) UVBinduced basal cell carcinoma formation in Ptch1^+/– mice. Fas expression is low in human and murine basal cell carcinomas but is up-regulated in the presence of the smoothened (SMO) antagonist, cyclopamine, both in vitro in the mouse basal cell carcinoma cell line ASZ001 and in vivo after acute treatment of mice with basal cell carcinomas. This parallels an elevated rate of apoptosis. Conversely, expression of activated SMO in C3H10T1/2 cells inhibits Fas expression. Fas/Fas ligand interactions are necessary for cyclopamine-mediated apoptosis in these cells, a process involving caspase-8 activation. Our data provide strong evidence that cyclopamine and perhaps other SMO antagonists are potent in vivo inhibitors of UVB-induced basal cell carcinomas in Ptch1^+/– mice and likely in humans because the majority of human basal cell carcinomas manifest mutations in PTCH1 and that a major mechanism of their inhibitory effect is through up-regulation of Fas, which augments apoptosis.

This article has been cited by other articles:

				J. P. C. da Cunha, P. A. F. Galante, J. E. de Souza, R. F. de Souza, P. M. Carvalho, D. T. Ohara, R. P. Moura, S. M. Oba-Shinja, S. K. N. Marie, W. A. Silva Jr, et al. Bioinformatics construction of the human cell surfaceome PNAS, September 29, 2009; 106(39): 16752 - 16757. [Abstract] [Full Text] [PDF]

				J. Xie Activation of Hedgehog Signaling in Human Cancer: Basic Mechanisms and Clinical Implications Am. Assoc. Cancer Res. Educ. Book, April 18, 2009; 2009(1): 25 - 41. [Full Text] [PDF]

				Y. Wang, Z. Zhou, C. T. Walsh, and A. P. McMahon Selective translocation of intracellular Smoothened to the primary cilium in response to Hedgehog pathway modulation PNAS, February 24, 2009; 106(8): 2623 - 2628. [Abstract] [Full Text] [PDF]

				I. Ecke, F. Petry, A. Rosenberger, S. Tauber, S. Monkemeyer, I. Hess, C. Dullin, S. Kimmina, J. Pirngruber, S. A. Johnsen, et al. Antitumor Effects of a Combined 5-Aza-2'Deoxycytidine and Valproic Acid Treatment on Rhabdomyosarcoma and Medulloblastoma in Ptch Mutant Mice Cancer Res., February 1, 2009; 69(3): 887 - 895. [Abstract] [Full Text] [PDF]

				P.-L. So, M. A. Fujimoto, and E. H. Epstein Jr. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis Mol. Cancer Ther., May 1, 2008; 7(5): 1275 - 1284. [Abstract] [Full Text] [PDF]

				C. Bond, Y. Tang, and C. A. Podlasek Neural Influences on Sonic Hedgehog and Apoptosis in the Rat Penis Biol Reprod, May 1, 2008; 78(5): 947 - 956. [Abstract] [Full Text] [PDF]

				S. Arad, E. Zattra, J. Hebert, E. H. Epstein Jr., D. A. Goukassian, and B. A. Gilchrest Topical Thymidine Dinucleotide Treatment Reduces Development of Ultraviolet-Induced Basal Cell Carcinoma in Ptch-1+/- Mice Am. J. Pathol., May 1, 2008; 172(5): 1248 - 1255. [Abstract] [Full Text] [PDF]

				R. K. Lindemann Stroma-Initiated Hedgehog Signaling Takes Center Stage in B-Cell Lymphoma Cancer Res., February 15, 2008; 68(4): 961 - 964. [Abstract] [Full Text] [PDF]

				S. Huang, J. He, X. Zhang, Y. Bian, L. Yang, G. Xie, K. Zhang, W. Tang, A. A. Stelter, Q. Wang, et al. Activation of the hedgehog pathway in human hepatocellular carcinomas Carcinogenesis, July 1, 2006; 27(7): 1334 - 1340. [Abstract] [Full Text] [PDF]

				M. Dean CANCER STEM CELLS: Redefining the Paradigm of Cancer Treatment Strategies Mol. Interv., June 1, 2006; 6(3): 140 - 148. [Abstract] [Full Text] [PDF]

				Y. Tang, E. A. Swietlicki, S. Jiang, K. K. Buhman, N. O. Davidson, L. C. Burkly, M. S. Levin, and D. C. Rubin Increased apoptosis and accelerated epithelial migration following inhibition of hedgehog signaling in adaptive small bowel postresection Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1280 - G1288. [Abstract] [Full Text] [PDF]

				C. Adolphe, R. Hetherington, T. Ellis, and B. Wainwright Patched1 Functions as a Gatekeeper by Promoting Cell Cycle Progression Cancer Res., February 15, 2006; 66(4): 2081 - 2088. [Abstract] [Full Text] [PDF]

				T. Sheng, S. Chi, X. Zhang, and J. Xie Regulation of Gli1 Localization by the cAMP/Protein Kinase A Signaling Axis through a Site Near the Nuclear Localization Signal J. Biol. Chem., January 6, 2006; 281(1): 9 - 12. [Abstract] [Full Text] [PDF]

				A. I. Rubin, E. H. Chen, and D. Ratner Basal-Cell Carcinoma. N. Engl. J. Med., November 24, 2005; 353(21): 2262 - 2269. [Full Text] [PDF]